Malaysia Clarifies Content, Language And Other Labeling Requirements For Devices, IVDs
Executive Summary
Manufacturers and authorized representatives operating in Malaysia must not place labels over a device’s lot/batch or serial number, date of manufacturing or date of expiry, says new guidance on how to label products.
You may also be interested in...
Global Medtech Guidance Tracker: February 2018
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Twenty-four new guidance documents were posted to the tracker since its last update.
Malaysia Moves: Asian Medtech Associations Regulatory Networking November 2017, Part I
The second Asian Medtech Associations Regulatory Networking discussion focused on a range of regional issues, including the latest on-the-ground news and views. Hosted by Medtech Insight, and sponsored by the Asia Regulatory and Quality Consultancy (ARQon), the Asia Regulatory Professionals Association (ARPA) and Medtronic, this session is reported in two parts, with this first part focusing on Malaysia.
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.